Health
Platform reveals insights into cancer genomics and personalised medicine – Drug Target Review
Researchers have developed a personalised medicine platform that they say could advance genomic medicine research for cancer.
Posted: 9 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have developed a personalised medicine platform that could advance genomic medicine research for cancer.
A team of researchers has developed a personalised genomic medicine platform that they say will help to accelerate genomic medicine research and genome-informed drug discovery. The study was conducted at the Cleveland Clinic, US.
Known as My Personal Mutanome (MPM), the platform features an interactive…
Continue Reading
